You are here » Home » Companies » Company Overview » Choksi Imaging Ltd

Choksi Imaging Ltd.

BSE: 530427 Sector: Consumer
NSE: N.A. ISIN Code: INE865B01016
BSE 00:00 | 30 Jun 37.00 2.15
(6.17%)
OPEN

38.50

HIGH

38.50

LOW

35.30

NSE 05:30 | 01 Jan Choksi Imaging Ltd
OPEN 38.50
PREVIOUS CLOSE 34.85
VOLUME 790
52-Week high 52.70
52-Week low 23.85
P/E
Mkt Cap.(Rs cr) 14
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 38.50
CLOSE 34.85
VOLUME 790
52-Week high 52.70
52-Week low 23.85
P/E
Mkt Cap.(Rs cr) 14
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Choksi Imaging Ltd. (CHOKSIIMAGING) - Director Report

Company director report

To

The Members

Choksi Imaging Limited

Your Directors have pleasure in presenting the 29th Annual Report of the Companytogether with the Audited Statements of Accounts for the year ended March 31 2021.

FINANCIAL STATEMENTS & RESULTS:

The Company's performance during the year ended March 312021 as compared to theprevious financial year is summarized below:

Rs. in Lakhs
Particulars 2020-2021 2019-2020
Total Revenue 1573.93 1706.11
Profit/(Loss) Before Depreciation Amortisation Exceptional & Extraordinary Items and Tax 289.18 (35.66)
Less: Depreciation and Amortisation expense 18.60 17.48
Profit/(Loss) Before Exceptional & Extraordinary Items And Tax 270.58 (53.14)
Net Profit/(Loss) Before Tax (NPBT) 270.58 (53.14)
Less: Tax expenses 79.78 2.42
Net Profit/(Loss) After Tax (NPAT) 190.80 (55.56)
Amount available for Appropriations 190.80 (55.56)

FINANCES

The total long term borrowings of your Company as on March 31 2021 stood at NIL Cashand Cash Equivalent stood at Rs.726.58 lakh and total investments is 78.03 lakh at the endof the year.

OPERATIONS

Your Company is engaged in the business of trading of X ray films and supply of otherproducts for the Healthcare Industry.

During the year under the review your Company earned a total income of Rs.1573.93 Lakhas against Rs.1706.11 Lakh during the previous year.

DIVIDEND

The Board has Recommended a final dividend @25% i.e. Rs.2.5/- per share (Rupee Two andFifty Paise only) on 3900000 fully paid up equity share capital of Rs.10/- each of theCompany for the financial year ended March 31 2021.

TRANSFERTO RESERVES:

The Company has not transfer any amount to General Reserves.

SHARE CAPITAL

The paid up Equity Share Capital as at March 31 2021 stood at Rs.390 lakh. During theyear under review the Company has not issued shares with differential voting rights norhas granted any stock options or sweat equity. As on March 31 2021 none of the Directorsof the Company hold instruments convertible into equity shares of the Company.

REVISION OF FINANCIAL STATEMENTS:

During the year under the review there is no change in accounting policy of theCompany.

REPORT ON PERFORMANCE OF SUBSIDIARIES ASSOCIATES AND JOINT VENTURE COMPANIES

During the year under review your Company did not have any subsidiary associate andjoint venture company.

CORPORATE GOVERNANCE REPORT & MANAGEMENT DISCUSSION AND ANALYSIS

As per Regulation 15 (2) read with Schedule V of the SEBI (Listing Obligations andDisclosure Requirements) Regulations 2015 the Company does not require to submitcorporate governance report.

A detailed report on Industry Structure and Developments Operations PerformanceBusiness Outlook Opportunities &Threats and Risks and Concerns is presented in aseparate section forming a part of the Annual Report.

DIRECTORS AND KEY MANAGERIAL PERSONNEL:

• Director Retiring by Rotation:

As per the provisions of Section 152 of the Companies Act 2013 Mr. Naimish Choksi andMr. Gaurav Choksi retires by rotation at the ensuing Annual General Meeting and beingeligible offer themselves for re-appointment. Your Directors recommend their approval.

• Expiry of term of Managing Director and Whole time Director:

The Nomination & Remuneration Committee and the Board have noted that term ofappointment of Mr. Anil Choksi as Managing Director and Mr. Samir Choksi as Whole timeDirector ceases w.e.f August 31 2021. The aforesaid Directors have not offered themselvesfor reappointment.

• Appointment of Independent Directors and declaration of independence:

During the year The Company has not appointed any Independent Director.

The Company has received declarations from all the Independent Directors of the Companyconfirming that they meet with the criteria of independence as prescribed undersub-section (6) of Section 149 of the Companies Act 2013.

• Appointment of Key Managerial Personnel:

Mr. Sunil Choksi - President Marketing of the Company and Mr. Tushar Choksi - PresidentAdministration of the Company have been appointed as an Executive Directors of the Companyin Board Meeting held on May 24 2021 and aforesaid Directors offered themselves to beregularize as Whole time Directors of the Company in ensuing AGM.

BOARD EVALUATION

Pursuant to the provisions of the Companies Act 2013 and Regulation 17 of the ListingRegulation and SEBI Circular the committee updates the criteria of Board evaluation. TheBoard has carried out performance evaluation.

REMUNERATION POLICY

The Company has adopted a Remuneration Policy for the Directors Key ManagerialPersonnel and other employees pursuant to the provisions of the Act and the ListingRegulations. The policy on Nomination & Remuneration of Directors and KMP is availableon website of the Company at www.choksiworld.com.

DIRECTOR'S RESPONSIBILITY STATEMENT

In terms of Section 134(5) of the Companies Act 2013 in relation to the auditedfinancial statements of the Company for the year ended March 312021 the Board ofDirectors hereby confirms that:

(a) In the preparation of the annual accounts the applicable accounting standards hadbeen followed along with proper explanation relating to material departures;

(b) the directors had selected such accounting policies and applied them consistentlyand made judgments and estimates that are reasonable and prudent so as to give a true andfair view of the state of affairs of the company at the end of the financial year and ofthe profit and loss of the company for that period;

(c) The directors had taken proper and sufficient care for the maintenance of adequateaccounting records in accordance with the provisions of this Act for safeguarding theassets of the company and for preventing and detecting fraud and other irregularities;

(d) The directors had prepared the annual accounts on a going concern basis;

(e) The directors in the case of a listed company had laid down internal financialcontrols to be followed by the company and that such internal financial controls areadequate and were operating effectively.

(f) The directors had devised proper systems to ensure compliance with the provisionsof all applicable laws and that such systems were adequate and operating effectively.

DETAILS OF BOARD AND COMMITTEES MEETING:

• Board Meetings:

The Board of Directors of the company met 4 times on June 17 2020 August 17 2020November 06 2020 January 30 2021 and March 222021.

• Committees of the Board:

With a view to have a more focused attention on business and for better governance andaccountability the Board has constituted the mandatory committees viz. Audit CommitteeStakeholders' Relationship Committee and Nomination and Remuneration Committee.

RELATED PARTY TRANSACTIONS :

All contracts / arrangements / transactions entered by the Company during the financialyear with related parties are given in Annexure I in form AOC-2.

Further during the year the Company had not entered into any contract / arrangement/transaction with related parties which could be considered material in accordance withthe policy of the Company on materiality of related party transactions. Prior omnibusapproval of the Audit Committee is obtained for the transactions which are repetitive innature. A statement of all Related Party Transactions is placed before the Audit Committeefor its review on a quarterly basis specifying the nature value and terms and conditionsof the transactions.

The details of the related party transactions as required under Accounting Standard -18 are set out in Note to the financial statements forming part of this Annual Report.

The Policy on Related Party Transactions as approved by the Board has been uploaded onthe website of the Company.

DEPOSITS

Your Company has not accepted any public deposits during the financial period underreview.

AUDITORS

• Statutory Auditors:

Pursuant to the provisions of Section 139 of the Companies Act 2013 and the Companies(Audit and Auditors) Rules 2014 M/s. KARIA & SHAH Chartered Accountants has beenappointed by the Board of Directors as Statutory Auditors of the Company from conclusionof 25th Annual General Meeting held on September 23 2017 till conclusion of 30th AnnualGeneral Meeting. The Company has received a confirmation from the Auditors that they arenot disqualified to act as the Auditors and are eligible to hold the office as Auditors ofthe Company.

• Secretarial Auditors:

Provisions of Section 204 read with rules made thereunder Ms. Nikita Pedhdiya NikitaPedhdiya & Associates Practicing Company Secretaries (C.P No. 14295) had beenappointed to undertake Secretarial Audit of the Company for the year 2020-2021. The reportof the Secretarial Auditor is annexed herewith as Annexure II and forms part of thisReport.

The said report does not contain any observation or qualification requiring explanationor comments from the Board under Section 134(3) of the Companies Act 2013.

• Internal Auditors:

Pursuant to provisions of Section 138 read with read with rules made thereunder theBoard has appointed M/s. R S Bindra & Company Chartered Accountants as an InternalAuditors of the Company for the period 2020 2021 to check the internal controls andfunctioning of the activities and recommend ways of improvement. The Internal Audit reportis placed in the Audit Committee Meeting and the Board Meeting for their consideration anddirection.

The Internal Financial Controls with reference to financial statements as designed andimplemented by the Company are adequate. During the year under review no material orserious observation has been received from the Internal Auditors of the Company forinefficiency or inadequacy of such controls.

AUDITORS' REPORT

In the opinion of the directors the notes to financial statements are self-explanatoryand adequately explain the matters which are dealt within the Auditors' Report.

The said report does not contain any observation or qualification requiring explanationor comments.

COST AUDITORS

Provisions of Section 148 of the Companies Act 2013 read with Notifications/Circularsissued by the Ministry of Corporate Affairs from time to time the requirement ofappointment of Cost Auditor is not applicable to your Company.

INTERNAL CONTROL & FINANCIAL REPORTING SYSTEMS

The Company has in place an adequate system of internal controls & policy onFinancial Statements. It has documented policies and procedures covering all financial andoperating functions and processes. These have been designed to provide a reasonableassurance with regard to maintaining of proper accounting controls for ensuringreliability of financial reporting monitoring of operations protecting assets fromunauthorized use or losses and compliance with regulations.

Adequate internal control systems commensurate with the nature of the Company'sbusiness and size and complexity of its operations has been recognized. Internal controlsystems ensure reliability of financial reporting timely feedback on achievement ofoperational and strategic goals compliance with applicable laws and regulations and thatall assets and resources are acquired economically used efficiently and adequatelyprotected.

RISK MANAGEMENT:

In accordance with Section 134 of Companies Act 2013 the Company has in place theRisk Assessment and Minimization Policy to avoid events situations or circumstances whichmay lead to negative consequences on the Company's businesses and define a structuredapproach to manage uncertainty and to make use of these in their decision makingpertaining to all business divisions and corporate functions. Key business risks and theirmitigation are considered in the business plans and in periodic management reviews.

The Constitution of Risk Management Committee is not applicable to your Company.

Some of the risks and threats that the company is exposed to are- TECHNOLOGICALOBSOLESCENCE

The company strongly believes that technological obsolescence is a practical reality.Technological obsolescence is evaluated on a continual basis. The use of technology ismainly concentrated in the area of manufacturing of Medical and Industrial X-ray films.The innovation and advancement in technology is concentrated on improving the quality ofthe films increasing the output by reducing the time-lag involved and reducing thewastages.

FLUCTUATIONS IN FOREIGN EXCHANGE

While our functional currency is the Indian rupee we transact a non-significantportion of our business in USD still face foreign currency exposure from our purchase inother countries and from our purchases from overseas suppliers in U.S. dollars and othercurrencies and are exposed to substantial risk on account of adverse currency movements inglobal foreign exchange markets.

LEGAL FACTORS

Legal risk is the risk in which the Company is exposed to legal action. As the Companyis governed by various laws and the Company has to do its business within four walls oflaw where the Company is exposed to legal risk exposure.

HUMAN RESOURCES:

The Company regards its human resource as amongst its most valuable assets andproactively reviews policies and processes by creating a work environment that encouragesinitiative provides challenges and opportunities and recognizes the performance andpotentials of its employees.

At CIL there is consistent emphasis on each individual's sense of responsibilitywhile simultaneously as part of a team. This results in our people's ability to work inperfect harmony despite coming from different disciplines. As of March 31 2021 thenumber of employees on our payroll were 32.

CONSERVATION OF ENERGY TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO

(A) Conservation of energy-

(I) The steps taken or impact on conservation of energy;

We had replaced Voltas Air Condition Plant which was having rotary compressors withBlue star Scroll compressor based plant. This has resulted in 25% saving in energyconsumption.

(ii) The steps taken by the company for utilising alternate sources of energy;

The Company is in process of installation of 7.5 KWp Grid Connected Rooftop Solar PVPlant at our Factory located in the State of Dadra and Nagar Haveli.

One (1) Kilo Watt system shall be generating approximately 1500 kwh per annum. The lifeof the project is considered for 25 years.

(iii) The capital investment on energy conservation equipments;

During the year the Company has invested and made advance payment of 50% onaforementioned solar plant.

(B) Technology absorption-

(I) the efforts made towards technology absorption;

The interleaving operation has been partially automated.

(ii) the benefits derived like product improvement cost reduction product developmentor import substitution; Improvement in product quality and reduction in production cost.

(iii) in case of imported technology (imported during the last three years reckonedfrom the beginning of the financial year)-

N.A.

(iv) the expenditure incurred on Research and Development.

N.A.

A. FOREIGN EXCHANGE EARNINGS AND OUTGO

The fluctuations in the market were high due to depreciation of rupee against thedollar but your Company was able to manage the volatility in a prudent manner due to whichlosses were minimized.

Sr. No Particulars Current Year (Rs. in lakh) Previous year ( Rs. in lakh)
1 Foreign Exchange Earnings Nil Nil
2 Foreign Exchange Outgo 1476.56 7.86

PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES

The information required under Section 197 of the Companies Act 2013 read withCompanies (Appointment and Remuneration of Managerial Personnel) Rules 2014 in respect ofemployees of the Company is provided in Annexure III forming part of this report.

DISCLOSURES AS PER RULE 5 OF COMPANIES (APPOINTMENT AND REMUNERATION OF MANAGERIALPERSONNEL) RULES 2014.

The ratio of the remuneration of each Director to the median remuneration of theemployees of the Company for the financial year under review has been disclosed inAnnexure III.

WHISTLE BLOWER POLICY /VIGIL MECHANISM POLICY.

The Company has adopted a Whistle Blower Policy to provide a formal mechanism to theDirectors and employees to report their concerns about unethical behaviour actual orsuspected fraud or violation of the Company's Code of Conduct or ethics policy. The Policyprovides for adequate safeguards against victimization of employees who avail of themechanism and also provides for direct access to the Chairman of the Audit Committee. Itis affirmed that no personnel of the Company has been denied access to the AuditCommittee.

SEXUAL HARRASMENT POLICY

In accordance with the Sexual Harassment of Women at Workplace (Prevention Prohibitionand Redressal) Act 2013 and rules made thereunder the Company has framed and adopted apolicy for Prevention of Sexual Harassment at Workplace.

The Company has not received any complaint of sexual harassment during the financialyear 2020-21.

CORPORATE SOCIAL RESPONSIBILITY

The Provisions of Section 135 of Companies Act 2013 is not applicable to your Company.

EXTRACT OF ANNUAL RETURN.

Extract of the Annual Return in form MGT-9 pursuant to Section 92(3) of the CompaniesAct 2013 for the financial year ended March 312021is available on the website of theCompany.

PARTICULARS OF LOANS GUARANTEES OR INVESTMENTS BY COMPANY.

The investment of Company in various Liquid Fund has stood at Rs.78.03 lakh. TheInvestment is calculated at market value as on March 312021.

The Company has not given any loans or provided any security during the year.

OTHER DISCLOSURE

• The Company has made payment of settlement amount of USD $1800000 toCarestream Health INC. on December 15 2020 on account of trade payable withhold by theCompany for amount of USD $2098845.Further the Company has also received amount ofiNr24804566 against trade receivables of the Company from Carestream Health IndiaPrivate Limited wholly owned subsidiary of Carestream Health INC. CHI has given corporateindemnity for 67% of all non-appealable cost in Customs case.

• The Company had decided to discontinue the manufacturing activities at itsfactory situated at Survey No.121 Plot No 10 Silvassa Industrial Estate 66 KVA RoadAmli Silvassa Dadra & Nagar Haveli DN 396230 IN from the end first quarter of2021-2022. The Company has been incurring operational losses for the last one year and dueto further upsurge in prices of raw material in international market and the drastic fallin demand for the products manufactured by the Company due to technology shift. Severalinitiatives such as substantial improvements in quality and service cost reduction etc.were taken in the past. However the performance of the Factory did not improve. As theFactory was considered no longer viable and after considering various options the Boarddecided that it is in best interest of the Company to sale the Factory unit to M/s. ChoksiAsia Private Limited along with Plant & Machinery to get optimum value.

The Company has obtained shareholders' approval for above by passing special resolutionvide postal ballot notice dated May 24 2021.

• Except above no other material changes and commitments which could affect theCompany's financial position have occurred between the end of the financial year of theCompany and date of this report.

• The Company had received an order from Commissioner of Customs from theAuthority for payment of Special Additional Duty along with penalty against exemptionavailed by the Company pursuant to Notification No. 45/2005 - Customs dated May 16 2005.

The Company has filed an appeal against order with Customs Excise & Service TaxAppellate Tribunal west zonal bench Mumbai on May 25 2015.

HEALTH AND SAFETY MEASURES

The standards of health of workers and safety measures to be taken as provided by theFactories Act 1948 and the rules framed there under have been maintained by your Companytill March 312021

CAUTIONARY STATEMENT

Statements in this Board's Report and Management Discussion and Analysis describing theCompany's objectives expectations or predictions may be forward looking within themeaning of applicable securities laws and regulations. Actual results may differmaterially from those expressed in the statement. Important factors that could influencethe Company's operations include change in government regulations tax laws economic& political developments within and outside the country and such other factors.

ACKNOWLEDGEMENTS AND APPRECIATION

Your Directors wish to thank all the employees of the Company for their dedicatedservice during the year. They would also like to place on record their appreciation forthe continued co-operation and support received by the Company during the year frombankers financial institutions business partners and other stakeholders.

Your Directors give their warm gratitude to the shareholders for their faith in theCompany. The directors also sincerely appreciate the professionalism and dedicationdisplayed by the employees of the Company.

On behalf of the Board of Directors

Sd/- Sd/-
Anil Choksi Gaurav Choksi
Director Director
Place: Mumbai
Date: August 12 2021

.